Vaginitis Diagnostics Market Growth Prospects, Trends and Forecast up to 2030

Vaginitis Diagnostics Market: Introduction Vaginitis is a condition in which vagina is inflamed resulting into itching, discharge and pain. In some women, decrease in estrogen levels after menopause and skin conditions could cause vaginitis. Major types of vaginitis conditions are bacterial vaginosis, yeast infections, and trichomoniasis. Read Report Overview - https://www.transparencymarketresearch.com/vaginitis-diagnosticsmarket.html Symptoms of vaginitis condition include vaginal itching, pain in urination, pain experienced during intercourse, and light vaginal bleeding or spotting. Most common reason behind vaginitis is due to imbalance in the bacteria found in the vagina. Bacterial vaginosis is the most common type and can lead to the complicated diseases such as sex transmitted diseases (STD), post-operative infections, HIV, and urinary tract infections. Diagnosis of vaginitis in early stage is estimated to further prevent the complications and worsening the condition. Vaginitis is most common in the women in its reproductive years affecting the age group from 15 to 44 years. Various treatments are available for the vaginitis condition including antibiotics and topical treatments such as gel or cream. Diagnosis of vaginitis infection includes Amsel criteria (vaginal ph should be greater than 4.5), milky discharge, whiff tests, and presence of clue cells in vaginal fluid. Rapid point-of-care tests considered to accurately diagnose the vaginitis disease. Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php? flag=B&rep_id=77295 Key Drivers and Restraints of Global Vaginitis Diagnostics Market Increase in incidence of vaginitis diseases, growing sexually transmitted diseases across the globe, and awareness about the vaginitis infection are major drivers of the global vaginitis diagnostics market. Faster adoption of clinical, OTC testing for accurate diagnosis of vaginitis are likely to drive the global market. Furthermore, vulvovaginitis is the most common cause of vaginal infection across the globe, and as per statistics, bacterial vulvovaginitis affects around 30% women across the U.S. These statistics are estimated to drive the need for proper diagnosis of vaginitis infection. Also, as per research performed by the CDC, in 2017, vaginal candidiasis (yeast infection) was the second most prevalent infection worldwide. Moreover, availability of the gynecological care for the proper diagnosis of vaginitis infection, changing lifestyle, improper hygiene, lack of attention for menstrual hygiene, and tight clothing are estimated to drive the vaginitis diagnostics market. Technological advancements, approval of innovative diagnostics test are likely to boost the vaginitis diagnostics market. Request for Analysis of COVID-19 Impact on Vaginitis Diagnostics Market https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=77295 For instance, in May 2019, Hologic, Inc. announced FDA approval for its Aptima BV and Aptima CV/TV assays as an accurate method for diagnosis of vaginitis. As per research, 90% of the vaginitis infections

Turn static files into dynamic content formats.

Create a flipbook